| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81a6e3f3c3eab77f906ab345643c2e33 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
| filingDate |
1995-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2005-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_853cec9f0078d9161b0dc2ce7d36cecc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97fd430162661e7a056ac8e16ffb75eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_612cabd24f1ad3f18907bd2cd659127b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efe85d542b76a2ec69670ae5bc62f465 |
| publicationDate |
2005-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2257662-C |
| titleOfInvention |
Quinoline derivatives as tachykinin nk3 receptor antagonists |
| abstract |
NK3 receptor antagonists of formula (I) are useful in treating inter alia pulmonary disorders, CNS disorders and neurodegenerative disorders. |
| priorityDate |
1994-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |